Single-cell sequencing comparing CCR5+ vs. CCR5− breast cancer cells from within a heterogeneous population of breast cancer patients revealed dramatic enrichment of pathways governing ribosomal biogenesis [11]. Here, CCR5 is linked to breast carcinoma.